Diarrhea (peds): Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
== | == DDX == | ||
===Infection=== | |||
#Viral | |||
##Rotavirus | |||
##Norwalk virus | |||
##Enteroviruses | |||
##Adenoviruses | |||
#Bacterial | |||
##Salmonella | |||
##Shigella | |||
##Yersinia | |||
##Campylobacter | |||
##Escherichia coli | |||
##Vibrio species | |||
##Clostridium difficile | |||
##TB | |||
#Parasitic | |||
##Giardia | |||
##Entamoeba | |||
##Cryptosporidia | |||
===Dietary disturbances=== | |||
#Overfeeding | |||
#Food allergy | |||
#Starvation stools | |||
===Anatomic abnormalities=== | |||
#Intussusception | |||
#Hirschsprung disease | |||
#Partial obstruction | |||
#Appendicitis | |||
#Blind loop syndrome | |||
#Intestinal lymphangiectasia | |||
#Short bowel syndrome | |||
===Malabsorption or secretory diseases=== | |||
##Cystic fibrosis | |||
##Celiac disease | |||
##Disaccharidase deficiency | |||
##Secretory neoplasms | |||
===Systemic diseases=== | |||
#Immunodeficiency | |||
#Endocrinopathy | |||
##Hyperthyroidism | |||
##Hypoparathyroidism | |||
##Congenital adrenal hyperplasia | |||
===Miscellaneous=== | |||
#Inflammatory bowel disease | |||
#Antibiotic-associated diarrhea | |||
#Secondary lactase deficiency | |||
#Irritable colon syndrome | |||
#Neonatal drug withdrawal | |||
#Toxins | |||
#Hemolytic uremic syndrome | |||
{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" | {| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" | ||
| Line 34: | Line 84: | ||
|} | |} | ||
<br> | |||
== Treatment == | |||
'''Diarrheal Pathogens in Children and Specific Therapy''' | |||
'''Diarrheal Pathogens in Children and Specific Therapy''' | |||
{| border="1" cellpadding="2" | {| border="1" cellpadding="2" | ||
|- | |- | ||
! align="left" | AGENT | ! align="left" | AGENT | ||
! align="left" | SPECIFIC THERAPY BEYOND SUPPORTIVE CARE | ! align="left" | SPECIFIC THERAPY BEYOND SUPPORTIVE CARE | ||
|- | |- | ||
| rowspan="2" align="left" | ''Campylobacter jejuni'' | | rowspan="2" align="left" | ''Campylobacter jejuni'' | ||
| align="left" | Azithromycin 12 mg/kg/day PO for 5 days ''or'' | | align="left" | Azithromycin 12 mg/kg/day PO for 5 days ''or'' | ||
|- | |- | ||
| align="left" | Erythromycin 30–50 mg/kg/day, divided, tid PO for 5–7 days | | align="left" | Erythromycin 30–50 mg/kg/day, divided, tid PO for 5–7 days | ||
|- | |- | ||
| align="left" | ''Clostridium difficile'' | | align="left" | ''Clostridium difficile'' | ||
| align="left" | Metronidazole 30 mg/kg/day, divided, qid PO for 7–10 days ''or'' | | align="left" | Metronidazole 30 mg/kg/day, divided, qid PO for 7–10 days ''or'' | ||
|- | |- | ||
| rowspan="2" align="left" | ''Escherichia coli'' | | rowspan="2" align="left" | ''Escherichia coli'' | ||
| align="left" | Azithromycin 12 mg/kg/day PO for 5 days ''or'' | | align="left" | Azithromycin 12 mg/kg/day PO for 5 days ''or'' | ||
|- | |- | ||
| align="left" | Trimethoprim-sulfamethoxazole 10 mg (TMP)/kg/day PO divided bid for 5–7 days | | align="left" | Trimethoprim-sulfamethoxazole 10 mg (TMP)/kg/day PO divided bid for 5–7 days | ||
|- | |- | ||
| align="left" | ''Giardia'' lamblia | | align="left" | ''Giardia'' lamblia | ||
| align="left" | Metronidazole 15 mg/kg/day PO, divided, tid for 5 days | | align="left" | Metronidazole 15 mg/kg/day PO, divided, tid for 5 days | ||
|- | |- | ||
| align="left" | ''Salmonella'' species | | align="left" | ''Salmonella'' species | ||
| align="left" | ''In toxic infants | | align="left" | ''In toxic infants <3'' ''mo''<nowiki>:</nowiki><br>Ampicillin 200 mg/kg/24 hours q6h for 7–10 days ''and''<br>Gentamicin 5–7.5 mg/kg/24 hours q8h IV | ||
|- | |- | ||
| rowspan="2" align="left" | ''Shigella'' species | | rowspan="2" align="left" | ''Shigella'' species | ||
| align="left" | Azithromycin 12 mg/kg/day PO for 5 days ''or'' | | align="left" | Azithromycin 12 mg/kg/day PO for 5 days ''or'' | ||
|- | |- | ||
| align="left" | Trimethoprim-sulfamethoxazole 10 mg (TMP)/kg/day, divided, bid for 5–7 days if susceptible | | align="left" | Trimethoprim-sulfamethoxazole 10 mg (TMP)/kg/day, divided, bid for 5–7 days if susceptible | ||
|- | |- | ||
| align="left" | ''Yersinia enterocolitica'' | | align="left" | ''Yersinia enterocolitica'' | ||
| align="left" | If patient is immunosuppressed, treat as for presumed sepsis | | align="left" | If patient is immunosuppressed, treat as for presumed sepsis | ||
|- | |- | ||
| align="left" | ''Vibrio'' | | align="left" | ''Vibrio'' | ||
| align="left" | None; severe diarrhea or cholera may benefit from antibiotics | | align="left" | None; severe diarrhea or cholera may benefit from antibiotics | ||
|} | |} | ||
== See Also == | == See Also == | ||
[[Dehydration]] | |||
[[Dehydration]] | |||
[[Nausea and Vomiting]] | [[Nausea and Vomiting]] | ||
== Sources == | == Sources == | ||
Rosen's, Tintinalli | |||
[[Category:Peds]] | [[Category:Peds]] [[Category:ID]] [[Category:GI]] | ||
[[Category:ID]] | |||
[[Category:GI]] | |||
Revision as of 00:15, 30 July 2011
DDX
Infection
- Viral
- Rotavirus
- Norwalk virus
- Enteroviruses
- Adenoviruses
- Bacterial
- Salmonella
- Shigella
- Yersinia
- Campylobacter
- Escherichia coli
- Vibrio species
- Clostridium difficile
- TB
- Parasitic
- Giardia
- Entamoeba
- Cryptosporidia
Dietary disturbances
- Overfeeding
- Food allergy
- Starvation stools
Anatomic abnormalities
- Intussusception
- Hirschsprung disease
- Partial obstruction
- Appendicitis
- Blind loop syndrome
- Intestinal lymphangiectasia
- Short bowel syndrome
Malabsorption or secretory diseases
- Cystic fibrosis
- Celiac disease
- Disaccharidase deficiency
- Secretory neoplasms
Systemic diseases
- Immunodeficiency
- Endocrinopathy
- Hyperthyroidism
- Hypoparathyroidism
- Congenital adrenal hyperplasia
Miscellaneous
- Inflammatory bowel disease
- Antibiotic-associated diarrhea
- Secondary lactase deficiency
- Irritable colon syndrome
- Neonatal drug withdrawal
- Toxins
- Hemolytic uremic syndrome
| Infection |
| Viral: rotavirus, Norwalk virus, enteroviruses, astroviruses, adenoviruses, caliciviruses |
| Bacterial: Salmonella, Shigella, Yersinia, Campylobacter, Escherichia coli, Aeromonas hydrophila, Vibrio species, Clostridium difficile, tuberculosis |
| Parasitic: Giardia lamblia, Entamoeba histolytica, Cryptosporidia |
| Dietary disturbances |
| Overfeeding, food allergy, starvation stools |
| Anatomic abnormalities |
| Intussusception, Hirschsprung disease, partial obstruction, appendicitis, blind loop syndrome, intestinal lymphangiectasia, short bowel syndrome |
| Inflammatory bowel disease |
| Malabsorption or secretory diseases |
| Cystic fibrosis, celiac disease, disaccharidase deficiency, acrodermatitis enteropathica, secretory neoplasms |
| Systemic diseases |
| Immunodeficiency, endocrinopathy (hyperthyroidism, hypoparathyroidism, congenital adrenal hyperplasia) |
| Miscellaneous |
| Antibiotic-associated diarrhea, secondary lactase deficiency, irritable colon syndrome, neonatal drug withdrawal, toxins, hemolytic uremic syndrome |
Treatment
Diarrheal Pathogens in Children and Specific Therapy
| AGENT | SPECIFIC THERAPY BEYOND SUPPORTIVE CARE |
|---|---|
| Campylobacter jejuni | Azithromycin 12 mg/kg/day PO for 5 days or |
| Erythromycin 30–50 mg/kg/day, divided, tid PO for 5–7 days | |
| Clostridium difficile | Metronidazole 30 mg/kg/day, divided, qid PO for 7–10 days or |
| Escherichia coli | Azithromycin 12 mg/kg/day PO for 5 days or |
| Trimethoprim-sulfamethoxazole 10 mg (TMP)/kg/day PO divided bid for 5–7 days | |
| Giardia lamblia | Metronidazole 15 mg/kg/day PO, divided, tid for 5 days |
| Salmonella species | In toxic infants <3 mo: Ampicillin 200 mg/kg/24 hours q6h for 7–10 days and Gentamicin 5–7.5 mg/kg/24 hours q8h IV |
| Shigella species | Azithromycin 12 mg/kg/day PO for 5 days or |
| Trimethoprim-sulfamethoxazole 10 mg (TMP)/kg/day, divided, bid for 5–7 days if susceptible | |
| Yersinia enterocolitica | If patient is immunosuppressed, treat as for presumed sepsis |
| Vibrio | None; severe diarrhea or cholera may benefit from antibiotics |
See Also
Sources
Rosen's, Tintinalli
